Rhumbline Advisers

Filing Details

13F-HR/A • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-29
Total Holdings
4,182
Total Value
106905259736
Accession Number
0001115418-25-000005
Form Type
13F-HR/A
CIK
0001115418
Manager Name
Rhumbline Advisers
Data Enrichment
81% identified
3,407 identified775 unidentified

Holdings

4,182 positions
Manager:
SEC
Search and click to pin securities to the top
Page 179 of 210
Contineum Therapeutics, Inc.
CTNM|21217B100
Shares:
7573(-8.0%)
Value:
$52.9M(-56.2%)
52989T102
52989T102
Shares:
1024(-1.7%)
Value:
$52.8M(-2.1%)
Hello Group Inc.
MOMO|423403104
Shares:
8352(-32.0%)
Value:
$52.7M(-44.3%)
GoHealth, Inc.
GOCO|38046W204
Shares:
4287(+2.9%)
Value:
$52.6M(-5.7%)
36318L203
36318L203
Shares:
2674(+0.0%)
Value:
$52.4M(-6.7%)
46429B499
46429B499
Shares:
2010(+23.3%)
Value:
$52.2M(+42.5%)
Nomad Foods Ltd
NOMD|G6564A105
Shares:
2653(+0.0%)
Value:
$52.1M(+17.1%)
Ramaco Resources, Inc.
METCB|75134P501
Shares:
7327(+2.1%)
Value:
$52.1M(-26.5%)
900148701
900148701
Shares:
16313(-59.5%)
Value:
$51.7M(-63.8%)
ZTO Express (Cayman) Inc.
ZTO|98980A105
Shares:
2604(-82.8%)
Value:
$51.7M(-82.6%)
Commercial Vehicle Group, Inc.
CVGI|202608105
Shares:
44818(-9.7%)
Value:
$51.5M(-58.1%)
ZYNEX INC
ZYXI|98986M103
Shares:
23382(+6.2%)
Value:
$51.4M(-70.8%)
UP Fintech Holding Ltd
TIGR|91531W106
Shares:
5912(-13.1%)
Value:
$50.8M(+15.6%)
RAPT Therapeutics, Inc.
RAPT|75382E109
Shares:
41620(-9.9%)
Value:
$50.8M(-30.4%)
46429B523
46429B523
Shares:
488(+40.2%)
Value:
$50.7M(+36.9%)
Bilibili Inc.
BILI|090040106
Shares:
2639(-33.3%)
Value:
$50.4M(-29.7%)
Acumen Pharmaceuticals, Inc.
ABOS|00509G209
Shares:
45516(-14.2%)
Value:
$50.1M(-45.1%)
035243104
035243104
Shares:
3547(+0.0%)
Value:
$49.8M(+11.8%)
HUTCHMED (China) Ltd
HCM|44842L103
Shares:
3300(-57.7%)
Value:
$49.6M(-55.8%)
84857N107
84857N107
Shares:
1220(+9.9%)
Value:
$49.6M(+3.5%)